4516: Nippon Shinyaku Co., Ltd. - Summary | Jitta

Nippon Shinyaku Co., Ltd.

TYO:4516

Price
¥3,579.00
Loss Chance
44.2%
5.97JITTA SCORE
13.62%Under Jitta Line
Jitta Ranking
22 / 181
764 / 3,495
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (59)
Recent Business Performance (40)
Financial Strength (89)
Return to Shareholders (59)
Competitive Advantage (59)
Jitta Signs
Revenue and EarningConsistent
Debt LevelLow Long Term Debt
Dividend PayoutIncreasing Every Year
CapExVery Low
Operating MarginDeclined
Recent Business PerformanceEarning decline 11.04% in the last year
SG&A to SalesIncreasing
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
5.97
13.62%
4.40
159.05%
4.43
178.81%
Pharmaceuticals
6.99
6.20%
5.07
48.31%
6.57
39.60%
COMPANY DESCRIPTION
Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. It offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases; health food ingredients, preservatives, protein preparations, and supplements. The company in the Strategic Partnership with Nippon Shinyaku to develop ATSN-10 that is in Phase I/II of clinical trials for the treatment of GUCY2D-mutant Leber congenital amaurosis; and RGX-121 for the treatment of mucopolysaccharidosis. Nippon Shinyaku Co., Ltd. was founded in 1911 and is headquartered in Kyoto, Japan.